{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:42:01Z","timestamp":1783024921810,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013575","name":"A Blade of Grass","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013575","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029613","name":"American Association of Obstetricians and Gynecologists Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.gore.2026.102104","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:14:47Z","timestamp":1778368487000},"page":"102104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Navigating the healthcare system with a BRCA1\/2 pathogenic variant: What do patients value?"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6103-3030","authenticated-orcid":false,"given":"Tina","family":"Karimaghaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie V","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B. Davis","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra","family":"Vanroboys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Danyal","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2026.102104_b0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.gore.2026.102104_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.gore.2026.102104_b0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41523-024-00686-8","article-title":"BRCA genetic testing and counseling in breast cancer: how do we meet our patients' needs?","volume":"10","author":"Dubsky","year":"2024","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.gore.2026.102104_b0020","first-page":"40","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN guidelines) (ed 2.2026). National Comprehensive Cancer","author":"Nccn","year":"2025","journal-title":"Network"},{"key":"10.1016\/j.gore.2026.102104_b0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2025.08.030","article-title":"Risk of melanoma among people with BRCA1 and BRCA2 pathogenic variants: a systematic review and meta-analysis","volume":"201","author":"Frontera","year":"2025","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102104_b0030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/bjs.11603","article-title":"Risk of colorectal cancer associated with BRCA1 and\/or BRCA2 mutation carriers: systematic review and meta-analysis","volume":"107","author":"Cullinane","year":"2020","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.gore.2026.102104_b0035","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/pros.23795","article-title":"The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: a meta-analysis","volume":"79","author":"Oh","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.gore.2026.102104_b0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13073-019-0691-1","article-title":"Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank","volume":"12","author":"Abul-Husn","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.gore.2026.102104_b0045","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2025.16372","article-title":"Pathogenic Germline Variants in Cancer Susceptibility Genes","volume":"334","author":"Idumah","year":"2025","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.gore.2026.102104_b0050","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jmedgenet-2017-105195","article-title":"Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population","volume":"55","author":"Manchanda","year":"2018","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.gore.2026.102104_b0055","unstructured":"Cheng HH, Giri VN, Goggins M, et al: NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026. J Natl Compr Canc Netw 24:2\u201310, 2026."},{"key":"10.1016\/j.gore.2026.102104_b0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22874","article-title":"Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States","volume":"3","author":"Guzauskas","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.gore.2026.102104_b0065","doi-asserted-by":"crossref","unstructured":"Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome. Obstet Gynecol 130:657\u2013659, 2017.","DOI":"10.1097\/AOG.0000000000002285"},{"key":"10.1016\/j.gore.2026.102104_b0070","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.6004\/jnccn.2016.0108","article-title":"Genetic\/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice guidelines in Oncology","volume":"14","author":"Provenzale","year":"2016","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.gore.2026.102104_b0075","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-15-1465","article-title":"Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: a Meta-analysis and Systematic Review","volume":"22","author":"Li","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gore.2026.102104_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102104_b0085","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2026.102104_b0090","doi-asserted-by":"crossref","unstructured":"Balma\u00f1a J, D\u00edez O, Rubio IT, et al: BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol 22 Suppl 6:vi31\u20134, 2011.","DOI":"10.1093\/annonc\/mdr373"},{"key":"10.1016\/j.gore.2026.102104_b0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gore.2026.102104_b0100","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.gore.2026.102104_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10689-022-00316-x","article-title":"Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?","volume":"22","author":"Kahn","year":"2023","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.gore.2026.102104_b0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11912-022-01254-8","article-title":"Helping patients Understand and Cope with BRCA Mutations","volume":"24","author":"Makhnoon","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.gore.2026.102104_b0115","article-title":"Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1\/2 mutation Carriers' experience with genetic testing and counseling","volume":"41","author":"Dibble","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.gore.2026.102104_b0120","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1200\/JCO.22.00303","article-title":"Cascade Testing for Hereditary Cancer Syndromes: should we move Toward Direct Relative Contact? a Systematic Review and Meta-Analysis","volume":"40","author":"Frey","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2026.102104_b0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1186\/s12913-022-08372-w","article-title":"A qualitative reflexive thematic analysis into the experiences of being identified with a BRCA1\/2 gene alteration: \u201cso many little, little traumas could have been avoided\u201d","volume":"22","author":"Warner","year":"2022","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.gore.2026.102104_b0130","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.pec.2017.03.013","article-title":"\u201cWhen information is not enough\u201d: a model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk","volume":"100","author":"Dean","year":"2017","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.gore.2026.102104_b0135","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of Web surveys: the Checklist for Reporting results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.gore.2026.102104_b0140","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V: Conceptual and design thinking for thematic analysis. US, Educational Publishing Foundation, 2022, pp 3\u201326.","DOI":"10.1037\/qup0000196"},{"key":"10.1016\/j.gore.2026.102104_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/26895269.2022.2129597","article-title":"Toward good practice in thematic analysis: avoiding common problems and be(com)ing a knowing researcher","volume":"24","author":"Braun","year":"2023","journal-title":"International Journal of Transgender Health"},{"key":"10.1016\/j.gore.2026.102104_b0150","first-page":"2713","article-title":"Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment","volume":"30","author":"Aviki","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.gore.2026.102104_b0155","article-title":"Financial Toxicity of Cancer Care: It's Time to Intervene","volume":"108","author":"Zafar","year":"2016","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.gore.2026.102104_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300852","article-title":"Logistic burdens of cancer care: a qualitative study","volume":"19","author":"Dona","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.gore.2026.102104_b0165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13053-019-0132-6","article-title":"Patients with pathogenic variants for breast cancer other than BRCA1 and BRCA2: qualitative interviews about health care experiences","volume":"17","author":"Clift","year":"2019","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.gore.2026.102104_b0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11606-016-3943-4","article-title":"Primary care clinicians' cancer genetic testing-related knowledge, attitudes, and communication behaviors: a systematic review and research agenda","volume":"32","author":"Hamilton","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.gore.2026.102104_b0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/gim.2014.101","article-title":"Primary-care clinicians' perceived barriers to integration of genetics services: a systematic review of the literature","volume":"17","author":"Mikat-Stevens","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.gore.2026.102104_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12687-023-00685-5","article-title":"\u201cThere should be one spot that you can go:\u201d BRCA mutation carriers' perspectives on cancer risk management and a hereditary cancer registry","volume":"15","author":"Hynes","year":"2024","journal-title":"J Community Genet."},{"key":"10.1016\/j.gore.2026.102104_b0185","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s10897-017-0187-3","article-title":"Evaluation of Breast Cancer patients with Genetic Risk in a University Hospital: before and after the Implementation of a Heredofamilial Cancer Unit","volume":"27","author":"Lobo","year":"2018","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.gore.2026.102104_b0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10689-010-9333-x","article-title":"Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1\/2 carriers","volume":"9","author":"Pichert","year":"2010","journal-title":"Fam. Cancer"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:02:10Z","timestamp":1781668930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S2352578926000846"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102104","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the healthcare system with a BRCA1\/2 pathogenic variant: What do patients value?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102104"}}